S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Apyx Medical Co. stock logo
APYX
Apyx Medical
$1.32
-5.0%
$1.82
$1.21
$7.97
$45.73M1.09149,363 shs89,880 shs
DNAA
Social Capital Suvretta Holdings Corp. I
$14.07
$11.74
$9.07
$17.44
$360.76M-0.02182,488 shs4.63 million shs
Liquidia Co. stock logo
LQDA
Liquidia
$13.86
+2.1%
$14.75
$5.71
$16.99
$1.03B0.16827,218 shs658,239 shs
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$67.62
-0.7%
$70.31
$67.51
$100.59
$244.48M0.1231,910 shs42,745 shs
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Apyx Medical Co. stock logo
APYX
Apyx Medical
-5.04%-7.04%-25.42%-33.67%-56.00%
DNAA
Social Capital Suvretta Holdings Corp. I
0.00%0.00%0.00%0.00%0.00%
Liquidia Co. stock logo
LQDA
Liquidia
+2.06%-6.54%-10.93%+3.90%+98.57%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
-0.73%-3.58%-1.49%-16.21%-28.89%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Apyx Medical Co. stock logo
APYX
Apyx Medical
4.1701 of 5 stars
3.54.00.04.22.41.70.6
DNAA
Social Capital Suvretta Holdings Corp. I
N/AN/AN/AN/AN/AN/AN/AN/A
Liquidia Co. stock logo
LQDA
Liquidia
1.9871 of 5 stars
3.31.00.00.01.84.20.6
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
3.4656 of 5 stars
0.05.01.74.23.41.71.3

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Apyx Medical Co. stock logo
APYX
Apyx Medical
3.00
Buy$6.17367.17% Upside
DNAA
Social Capital Suvretta Holdings Corp. I
N/AN/AN/AN/A
Liquidia Co. stock logo
LQDA
Liquidia
2.60
Moderate Buy$21.0051.52% Upside
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/AN/AN/AN/A

Current Analyst Ratings

Latest LQDA, APYX, UTMD, and DNAA Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/10/2024
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
4/1/2024
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
3/14/2024
Liquidia Co. stock logo
LQDA
Liquidia
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$16.00 ➝ $32.00
3/13/2024
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
2/21/2024
Liquidia Co. stock logo
LQDA
Liquidia
Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$28.00
(Data available from 4/18/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Apyx Medical Co. stock logo
APYX
Apyx Medical
$52.35M0.87N/AN/A$0.78 per share1.69
DNAA
Social Capital Suvretta Holdings Corp. I
N/AN/AN/AN/A($0.33) per shareN/A
Liquidia Co. stock logo
LQDA
Liquidia
$17.49M60.25N/AN/A$0.73 per share18.99
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$50.22M4.83$6.29 per share10.75$35.35 per share1.91

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Apyx Medical Co. stock logo
APYX
Apyx Medical
-$18.71M-$0.54N/AN/AN/A-35.75%-54.90%-28.41%5/9/2024 (Estimated)
DNAA
Social Capital Suvretta Holdings Corp. I
-$2.44MN/A0.00N/AN/AN/A-3.32%N/A
Liquidia Co. stock logo
LQDA
Liquidia
-$78.50M-$1.20N/AN/AN/A-448.89%-132.16%-65.35%5/2/2024 (Estimated)
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$16.64M$4.5714.80N/A33.12%13.53%12.68%4/23/2024 (Estimated)

Latest LQDA, APYX, UTMD, and DNAA Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
3/21/2024Q4 2023
Apyx Medical Co. stock logo
APYX
Apyx Medical
-$0.13-$0.19-$0.06-$0.10$14.40 million$14.66 million
3/13/2024Q4 2023
Liquidia Co. stock logo
LQDA
Liquidia
-$0.23-$0.42-$0.19-$0.42$5.29 million$4.53 million
1/30/2024Q4 2023
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A$1.18+$1.18$1.18N/A$12.33 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Apyx Medical Co. stock logo
APYX
Apyx Medical
N/AN/AN/AN/AN/A
DNAA
Social Capital Suvretta Holdings Corp. I
N/AN/AN/AN/AN/A
Liquidia Co. stock logo
LQDA
Liquidia
N/AN/AN/AN/AN/A
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
$1.201.77%+1.75%26.26%2 Years

Latest LQDA, APYX, UTMD, and DNAA Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
2/6/2024
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
quarterly$0.301.6%3/14/20243/15/20244/3/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Apyx Medical Co. stock logo
APYX
Apyx Medical
1.23
5.52
4.74
DNAA
Social Capital Suvretta Holdings Corp. I
N/A
0.09
0.09
Liquidia Co. stock logo
LQDA
Liquidia
N/A
4.85
4.85
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
N/A
22.56
20.53

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Apyx Medical Co. stock logo
APYX
Apyx Medical
55.33%
DNAA
Social Capital Suvretta Holdings Corp. I
N/A
Liquidia Co. stock logo
LQDA
Liquidia
64.54%
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
69.60%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Apyx Medical Co. stock logo
APYX
Apyx Medical
25234.64 million30.11 millionOptionable
DNAA
Social Capital Suvretta Holdings Corp. I
425.64 millionN/ANot Optionable
Liquidia Co. stock logo
LQDA
Liquidia
14576.03 million52.00 millionOptionable
Utah Medical Products, Inc. stock logo
UTMD
Utah Medical Products
1693.59 million3.36 millionNot Optionable

LQDA, APYX, UTMD, and DNAA Headlines

SourceHeadline
Hurdles in Utah push medical cannabis patients toward out-of-state products.Hurdles in Utah push medical cannabis patients toward out-of-state products.
cityweekly.net - April 17 at 6:18 PM
Advance directives help people plan for their future medical care and quality of lifeAdvance directives help people plan for their future medical care and quality of life
msn.com - April 12 at 5:30 PM
2 Beaten-Down Stocks That Could Be Ready to Soar2 Beaten-Down Stocks That Could Be Ready to Soar
fool.com - April 11 at 5:33 AM
Utah Department of Agriculture unveils new analysis of Utahs Medical Cannabis marketUtah Department of Agriculture unveils new analysis of Utah's Medical Cannabis market
cachevalleydaily.com - April 9 at 4:39 PM
Intermountain Health’s Transplant Program and patients celebrate life-saving medical milestoneIntermountain Health’s Transplant Program and patients celebrate life-saving medical milestone
msn.com - March 14 at 10:05 PM
Utah at the forefront of Americas alarming prescription drug shortagesUtah at the forefront of America's alarming prescription drug shortages
ksl.com - March 12 at 6:37 PM
Utah at the forefront of America’s alarming prescription drug shortagesUtah at the forefront of America’s alarming prescription drug shortages
msn.com - March 11 at 9:12 PM
Utah Valleys 1st osteopathic college to host grand opening for innovative buildingUtah Valley's 1st osteopathic college to host grand opening for 'innovative' building
ksl.com - March 4 at 2:15 PM
Utah Medical Products, Inc.s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?Utah Medical Products, Inc.'s (NASDAQ:UTMD) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
finance.yahoo.com - March 4 at 8:49 AM
Utah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiumsUtah’s 2024 legislative session bookended by DEI, transgender issues and new baseball, hockey stadiums
msn.com - March 3 at 9:18 AM
Utah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outageUtah Medicaid to provide up to 30-day supply of medication at no cost amid cyber outage
msn.com - February 25 at 2:35 PM
Utah affected by E. coli contamination in raw milk cheeseUtah affected by E. coli contamination in raw milk cheese
news.yahoo.com - February 18 at 2:20 PM
Utah Medical Products, Inc. Announces Quarterly DividendUtah Medical Products, Inc. Announces Quarterly Dividend
finance.yahoo.com - February 6 at 12:42 PM
Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)Utah Medical Products Full Year 2023 Earnings: EPS: US$4.57 (vs US$4.53 in FY 2022)
finance.yahoo.com - January 31 at 5:58 PM
Utah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial PerformanceUtah Medical Products, Inc.: UTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
finanznachrichten.de - January 30 at 7:07 PM
UTMD Reports Audited Year 2023 and Fourth Quarter Financial PerformanceUTMD Reports Audited Year 2023 and Fourth Quarter Financial Performance
finance.yahoo.com - January 30 at 7:07 PM
Utah Medical Products Inc (UTMD) Reports Mixed 2023 Financial ResultsUtah Medical Products Inc (UTMD) Reports Mixed 2023 Financial Results
finance.yahoo.com - January 30 at 7:07 PM
Investors Could Be Concerned With Utah Medical Products (NASDAQ:UTMD) Returns On CapitalInvestors Could Be Concerned With Utah Medical Products' (NASDAQ:UTMD) Returns On Capital
finance.yahoo.com - January 26 at 11:24 AM
Big changes made to Utah’s controversial bathroom bill, but concerns remainBig changes made to Utah’s controversial bathroom bill, but concerns remain
yahoo.com - January 25 at 4:01 AM
Should cold plunge tubs be regulated in Utah? Here’s what a legislative committee decidedShould cold plunge tubs be regulated in Utah? Here’s what a legislative committee decided
msn.com - January 20 at 12:12 AM
The magic behind the high-impact discoveries from Utah’s universitiesThe magic behind the high-impact discoveries from Utah’s universities
news.yahoo.com - January 19 at 7:12 PM
Utah Medical Products, Inc. (UTMD)Utah Medical Products, Inc. (UTMD)
finance.yahoo.com - January 17 at 3:59 PM
Doctors urge Utah lawmakers to take immediate action on Great Salt LakeDoctors urge Utah lawmakers to take immediate action on Great Salt Lake
msn.com - January 11 at 12:19 AM
University of Utah president discontinues diversity statements, says they will no longer be used in hiringUniversity of Utah president discontinues diversity statements, says they will no longer be used in hiring
foxnews.com - January 10 at 4:17 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Apyx Medical logo

Apyx Medical

NASDAQ:APYX
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Social Capital Suvretta Holdings Corp. I

NASDAQ:DNAA
Social Capital Suvretta Holdings Corp. I does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.
Liquidia logo

Liquidia

NASDAQ:LQDA
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company also offers Remodulin, a treprostinil administered through continuous intravenous and subcutaneous infusion. The company also a license agreement with Pharmosa Biopharm Inc to develop and commercialize L606, an inhaled sustained-release formulation of Treprostinil for the treatment of PAH and PH-ILD. Liquidia Corporation was founded in 2004 and is headquartered in Morrisville, North Carolina.
Utah Medical Products logo

Utah Medical Products

NASDAQ:UTMD
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.